Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension (Q36203104)

12 August 2017

1 reference

title

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension (English)

1 reference

12 August 2017

0 references

Gregory D Lewis

1

1 reference

12 August 2017

Marc J Semigran

series ordinal

2

1 reference

12 August 2017

publication date

1 December 2004

1 reference

Current heart failure reports

12 August 2017

published in

1 reference

12 August 2017

volume

1

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

183-189

1 reference

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

12 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-004-0007-6

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-004-0007-6

Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management

21 January 2018

1 reference

12 December 2020

Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease

1 reference

12 December 2020

Hemodynamic effects of inhaled nitric oxide in heart failure

1 reference

12 December 2020

Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene

1 reference

12 December 2020

Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness

1 reference

12 December 2020

Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises

1 reference

12 December 2020

Pulmonary thromboembolism superimposed on a congenital ventricular septal defect in a 50-year-old man inhaled nitric oxide and sildenafil to the rescue

1 reference

12 December 2020

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

1 reference

12 December 2020

Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure

1 reference

12 December 2020

Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors

1 reference

12 December 2020

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

1 reference

12 December 2020

Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure

1 reference

12 December 2020

Inhaled nitric oxide: basic biology and clinical applications

1 reference

12 December 2020

Milrinone: a positive inotropic vasodilator

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

12 December 2020

Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

1 reference

12 December 2020

Sildenafil inhibits hypoxia-induced pulmonary hypertension

1 reference

12 December 2020

Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase

1 reference

12 December 2020

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide

1 reference

12 December 2020

Sildenafil citrate does not affect cardiac contractility in human or dog heart

1 reference

12 December 2020

Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure

1 reference

12 December 2020

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure

1 reference

12 December 2020

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

1 reference

12 December 2020

Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression.

1 reference

12 December 2020

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

1 reference

12 December 2020

Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo

1 reference

12 December 2020

Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction

1 reference

12 December 2020

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

1 reference

12 December 2020

Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature

1 reference

12 December 2020

Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.

1 reference

12 December 2020

Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure

1 reference

12 December 2020

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension

1 reference

12 December 2020

Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension

1 reference

12 December 2020

The natriuretic peptides in heart failure: diagnostic and therapeutic potentials

1 reference

12 December 2020

Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension

1 reference

12 December 2020

Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine

1 reference

12 December 2020

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

12 December 2020

Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device

1 reference

12 December 2020

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

12 December 2020

Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial

1 reference

12 December 2020

Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase

1 reference

12 December 2020

Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity.

1 reference

12 December 2020

10.1007/S11897-004-0007-6

Identifiers

DOI

1 reference

12 August 2017

1 reference